2 fantastic ASX 200 shares to buy right now

These ASX 200 shares could be in the buy zone now…

| More on:
A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you have room for a share or two in your portfolio then take a look at the excellent ASX 200 shares listed below.

Analysts have recently tipped these shares as ones to buy. Here's what you need to know:

CSL Limited (ASX: CSL)

The first ASX 200 share for investors to look at is CSL. It is one of the world's leading biotechnology companies and the name behind the CSL Behring and Seqirus businesses. Both are leaders in their respective fields of plasma therapies and vaccines.

In addition, the company is in the process of making a major acquisition. It is aiming to acquire Vifor Pharma, which is a leader in iron deficiency, nephrology and cardio-renal therapies, for $16.4 billion.

Citi is a fan of CSL. It recently upgraded the company's shares to a buy rating with a $340.00 price target.

It was pleased with the acquisition of Vifor, commenting: "Because of the large difference in the earnings multiples of both companies and the low cost of debt, we expect the transaction to be double digit NPATA accretive (although ROIC dilutive). The key positive from the transaction is that it expands the CSL late stage R&D pipeline, which we have noted for some time was limited for a company the size of CSL."

Wesfarmers Ltd (ASX: WES)

Another ASX 200 share to look at is Wesfarmers. It is the conglomerate behind several popular retail brands such as Bunnings and Kmart. It also has a diverse portfolio of industrial businesses.

While FY 2022 has been a tough year because of lockdowns and other COVID headwinds, the company looks well-placed for the future thanks to its strong brands, diverse operations, and balance sheet strength. The latter looks set to support M&A activity and the potential expansion into the healthcare sector.

Morgans is very positive on the company. It currently has an add rating and $60.80 price target on its shares.

The broker recently commented: "The company is run by a highly regarded management team and the balance sheet is healthy. While COVID-related staff shortages are proving to be a challenge, the core Bunnings division (>60% of group EBIT) remains a solid performer as consumers continue to invest in their homes. We see the recent pullback in the share price as a good entry point for longer term investors."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia owns and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

Man sits smiling at a computer showing graphs
Blue Chip Shares

3 ASX shares Australians can buy and hold for the next decade

Analysts think these high quality stocks could be in the buy zone right now.

Read more »

2 women looking at phone
Blue Chip Shares

3 high quality blue chip ASX 200 shares to buy in November

Here are a few blue chip shares that have been rated as buys this month by analysts.

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Blue Chip Shares

2 of the highest-quality blue chip ASX 200 stocks money can buy

Analysts think these blue chips are top buys for investors right now. But why?

Read more »

Three smiling corporate people examine a model of a new building complex.
Blue Chip Shares

This blue chip ASX 200 stock is 'among the highest-quality names' under coverage

Goldman Sachs thinks this blue chip is a top buy.

Read more »

A business woman flexes her muscles overlooking a city scape below.
Blue Chip Shares

Brokers name 2 strong ASX 200 shares to buy now

These shares are among the top picks on the benchmark ASX 200 index according to analysts.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Blue Chip Shares

Up 47% in a year: This blue chip ASX 200 stock can keep rising

Bell Potter is feeling bullish about this stock. But why?

Read more »

A man looking at his laptop and thinking.
Blue Chip Shares

Should you buy Coles and Mineral Resources shares this month?

Are these blue chips buys? Let's see what Bell Potter is saying about them.

Read more »

Happy man working on his laptop.
Blue Chip Shares

These big ASX 200 blue chip shares could rise 20% to 50%

Analysts think these blue chips could be cheap at current levels.

Read more »